Over 50,000 claimants accept Purdue Pharma settlement agreement
Over 50,000 claimants accept Purdue settlement; roughly 200 reject it.
Event / Health
Purdue Pharma OxyContin Settlement
Purdue Pharma was sentenced and will dissolve following a $5.5 billion settlement resolving thousands of opioid lawsuits. The company pleaded guilty to fraud and kickback conspiracy charges. The Sackler family must contribute up to $7 billion over 15 years, and individual victims will receive $8,000-$16,000 in compensation.
2 reported locations
Daily activity
0 articles0 articles
2026-08-18 to 2026-11-15 · UTC publication dates
Coverage begins 29 Apr, 07:36 UTC
Follow the documented timeline or explore the related reporting.
What happened
Over 50,000 claimants accept Purdue Pharma settlement; around 200 oppose it
Over 50,000 individual claimants accepted the Purdue Pharma settlement, while approximately 200 claimants opposed it. Some victim families stated the settlement does not go far enough and called for criminal charges against the company's owners. Some claimants face rejection from settlement payments due to inability to locate decades-old prescriptions proving they were prescribed OxyContin.
Judge criticizes federal government for approving OxyContin without catching abuse signs
Judge Arleo directed criticism at the federal government for approving OxyContin and not catching warning signs that it was being abused, and for prosecutors not bringing charges against individuals. She noted the disparity in sentencing, stating that she has sentenced convicted drug dealers to prison for selling OxyContin but those who started the epidemic will not serve a sentence.
Individual opioid victims to receive $8,000 to $16,000 in settlement payments
Payments to individual victims or their survivors from the Purdue Pharma settlement are expected to range from approximately $8,000 to $16,000. This settlement is among the largest in a series of recent settlements by drugmakers, wholesalers and pharmacies, and is the only major one that includes payments for some individual victims or survivors.
Purdue Pharma pleads guilty to fraud and kickback conspiracy charges
Purdue Pharma admitted to lacking an effective program to prevent diversion of prescription painkillers to the black market despite telling the DEA it had such a program. The company also admitted to paying doctors through a speakers program to prescribe opioids and paying an electronic medical records company to send doctors information encouraging more opioid prescriptions.
No individual criminal charges brought against Purdue Pharma employees or owners
Only Purdue Pharma as a company was charged in the criminal case; no individual employees or owners, including members of the Sackler family, received criminal charges. The guilty plea and civil settlement with the federal government included $8.3 billion in forfeitures, fines and penalties but did not include restitution to victims.
Purdue Pharma sentenced to $5.5 billion in criminal penalties
Purdue Pharma received criminal penalties totaling $5.5 billion related to fraud and kickback conspiracy charges. Of this amount, $225 million will be paid to the Department of Justice, with the remainder used in settlement payments to resolve thousands of individual opioid-related lawsuits.
Federal judge sentences Purdue Pharma in criminal case resolving DOJ probe
U.S. District Judge Madeline Cox Arleo sentenced Purdue Pharma on Tuesday, delivering a criminal sentence to resolve a Department of Justice investigation into the company's opioid operations. The judge characterized the company's actions as "a purposeful, intentional and sophisticated crime scheme" and noted sympathy for victims of the epidemic linked to over 900,000 deaths in the U.S. since 1999.
Sackler family granted legal shield from future opioid lawsuits
As part of the settlement, members of the Sackler family will be shielded from lawsuits over opioids from those who agree to the settlement payments. The family has also agreed not to object if their names are removed from museums and other institutions they have supported.
Purdue Pharma to dissolve and be replaced by public health-focused company
Purdue Pharma will cease to exist and be replaced by a new company called Knoa Pharma with a board appointed by the states, aimed at combating the opioid crisis. The dissolution is set to take effect by week's end following the judge's approval of the criminal sentence. Millions of internal Purdue documents will be made public as part of the settlement.
Sackler family to contribute up to $7 billion to opioid crisis settlement
Members of the Sackler family, who own Purdue Pharma, are required to contribute up to $7 billion over 15 years as part of the settlement. Most of the money is designated to go to government entities to use in fighting the opioid crisis. Family members received approximately $10.7 billion in payments from the company between 2008 and 2018, though they stated nearly half was used to pay taxes on behalf of the business.
Read the coverage
2 alternative perspectives
Federal judge faults regulators for missing OxyContin abuse warning signs
Federal judge faults government for missing OxyContin abuse signals during FDA approval process.
Sackler family secures legal immunity while pledging billions
Sacklers to pay billions but gain legal immunity with no individual criminal charges.
Purdue Pharma pleads guilty, faces dissolution and $5.5B penalty
Purdue Pharma pleads guilty to fraud, faces $5.5B penalty and dissolution.